Amedeo's Top 20

Amedeo Smart

Independent Medical Education

07 February 2022

Multidisciplinary Journal Club

  1. Atmar RL, Lyke KE, Deming ME, Jackson LA, et al.
    Homologous and Heterologous Covid-19 Booster Vaccinations.
    N Engl J Med 2022.

  1. Heesakkers H, van der Hoeven JG, Corsten S, Janssen I, et al.
    Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19.
    JAMA 2022.

  2. Feuerstadt P, Louie TJ, Lashner B, Wang EEL, et al.
    SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection.
    N Engl J Med 2022;386:220-229.

  3. Royce M, Osgood C, Mulkey F, Bloomquist E, et al.
    FDA Approval Summary: Abemaciclib With Endocrine Therapy for High-Risk Early Breast Cancer.
    J Clin Oncol 2022.

  4. Tosserams A, Weerdesteyn V, Bal T, Bloem BR, et al.
    Cortical correlates of gait compensation strategies in Parkinson's disease.
    Ann Neurol 2022.

  1. Rafn BS, Christensen J, Larsen A, Bloomquist K, et al.
    Prospective Surveillance for Breast Cancer-Related Arm Lymphedema: A Systematic Review and Meta-Analysis.
    J Clin Oncol 2022.

  2. Agopian VG, Markovic D, Klintmalm GB, Saracino G, et al.
    Multicenter validation of the liver graft assessment following transplantation (L-GrAFT) score for assessment of early allograft dysfunction.
    J Hepatol 2021;74:881-892.

  3. Azizi F, Abdi H, Mehran L, Amouzegar A, et al.
    Appropriate duration of antithyroid drug treatment as a predictor for relapse of Graves' disease: a systematic scoping review.
    J Endocrinol Invest 2022.

  4. Zhang X, Molsberry SA, Yeh TS, Cassidy A, et al.
    Intake of Flavonoids and Flavonoid-Rich Foods, and Mortality Risk Among Individuals With Parkinson Disease: A Prospective Cohort Study.
    Neurology 2022.

  5. Tominaga A, Wada K, Okazaki K, Nishi H, et al.
    Effect of the duration of previous osteoporosis treatment on the effect of romosozumab treatment.
    Osteoporos Int 2022.

  1. Nguyen TTA, Postlewait LM, Zhang C, Meisel JL, et al.
    Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancer.
    Breast Cancer Res Treat 2022.

  2. Paakinaho A, Koponen M, Tiihonen M, Kauppi M, et al.
    Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease: Nested Case-Control Study of People With Rheumatoid Arthritis.
    Neurology 2022.

  3. Wei J, Choi HK, Neogi T, Dalbeth N, et al.
    Allopurinol Initiation and All-Cause Mortality Among Patients With Gout and Concurrent Chronic Kidney Disease : A Population-Based Cohort Study.
    Ann Intern Med 2022.

  4. Tarabar D, El Jurdi K, Traboulsi C, Yvellez O, et al.
    A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab.
    Inflamm Bowel Dis 2022.

  5. Travers CP, Gentle S, Freeman AE, Nichols K, et al.
    A Quality Improvement Bundle to Improve Outcomes in Extremely Preterm Infants in the First Week.
    Pediatrics 2022.

  1. Lehrer EJ, Gurewitz J, Bernstein K, Patel D, et al.
    Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter study.
    Cancer 2022.

  2. Chou R, Dana T, Haymart MR, Leung AM, et al.
    Active surveillance versus thyroid surgery for differentiated thyroid cancer: A systematic review.
    Thyroid 2022.

  3. Osiyemi O, De Wit S, Ajana F, Bisshop F, et al.
    Efficacy and Safety of Switching to Dolutegravir/Lamivudine (DTG/3TC) Versus Continuing a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With HIV-1: Results Through Week 144 From
    Clin Infect Dis 2022.

  4. Andersen JH, Karlsen A, Geisler A, Jaeger P, et al.
    Alpha2 -receptor agonists as adjuvants for brachial plexus nerve blocks-A systematic review with meta-analyses.
    Acta Anaesthesiol Scand 2022;66:186-206.

  5. Zick JL, Staglin B, Vinogradov S.
    Eliminate schizophrenia.
    Schizophr Res 2022.


more..

Privacy Policy